Julie Taub, MD
Associate Professor, Medicine-Hospital Medicine

Publications

• Terasaki D, Loh R, Cornell A, Taub J, Thurstone C. Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates. Addict Sci Clin Pract. 2022 Nov 22;17(1):64. PubMed PMID: 36419181
• Arifkhanova A, Prieto JT, Davidson AJ, Al-Tayyib A, Hawkins E, Kraus E, McEwen D, Podewils LJ, Foldy S, Gillespie E, Taub J, Shlay JC. Defining Opioid-related Problems Using a Health Care Safety Net Institution's Inpatient Electronic Health Records: Limitations of Diagnosis-based Definitions. J Addict Med. 2022 Aug 1. [Epub ahead of print] PubMed PMID: 35914026
• Simpson SA, Taub J. “Management of the emergency department patient with co-occurring substance use disorder.” Chapter 6 in Behavioral Emergencies for Healthcare Providers, 2nd edition. Eds Zun LS, Nordstrom K, Wilson MP. New York: Springer. 2021.
• Arifkhanova A, McCormick Kraus E, Al-Tayyib A, Taub J, Encinias A, McEwen D, Davidson A, Shlay JC. Estimating costs of hospitalizations associated with opioid use disorder or opioid misuse at a large, urban safety-net hospital-Denver, Colorado, 2017. Drug Alcohol Depend. 2020 Sep 21;:108306. [Epub ahead of print] PubMed PMID: 33160792
• Nelson AC, Kaucher KA, Sankoff J, Mintzer D, Taub J, Kehoe J. Incorporating phenobarbital into your symptom-based benzodiazepine alcohol withdrawal protocol in the emergency department. Am J Emerg Med. 2018 Nov;36(11):2120-2121. PubMed PMID: 29685362